About Arda Therapeutics
Arda Therapeutics is a private company based in San Carlos, California, incorporated in 2021 in Delaware. It has reported $50,803,364 raised in two offerings on Form D since January 2022. Its chief executive is Adam Freund.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 16, 2024 | Oct 2, 2024 | $43,303,366of $43.4M target | 17 | $2.5M | EquityRule 506(b) | Form D ↗ |
| Dec 17, 2021 | Jan 14, 2022 | $7,499,998of $8.4M target | 10 | $749K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $50,803,364 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Arda Therapeutics's Form D filed Oct 2, 2024.
AF
Adam Freund
Chief Executive Officer and director